Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study.

Jiang, Xiaofan; Chen, Guanglei; Sun, Lisha; Liu, Chao; Zhang, Yu; Liu, Mingxin; Liu, Caigang

Jiang, Xiaofan; Chen, Guanglei; Sun, Lisha; Liu, Chao; Zhang, Yu; Liu, Mingxin; Liu, Caigang.

Afiliación

Jiang X; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Chen G; Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Shengjing Hospital of China Medical University, Shenyang, China.
Sun L; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Liu C; Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Shengjing Hospital of China Medical University, Shenyang, China.
Zhang Y; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Liu M; Innovative Cancer Drug Research and Development Engineering Center of Liaoning Province, Shengjing Hospital of China Medical University, Shenyang, China.
Liu C; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.

Front Oncol ; 12: 977226, 2022.

Article en En | MEDLINE | ID: mdl-36091103

Palabras clave

HER2 status; SEER (Surveillance Epidemiology and End Results) database; bone metastasis; breast cancer; hormone receptor (HR)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google